ARTHROPLASTY
TKA: Periarticular drug injection added to standard analgesia decreases pain
This report has been verified
by one or more authors of the
original publication.
Knee. 2012 Aug;19(4):253-9. Epub 2011 Apr 19
101 patients undergoing total knee arthroplasty (TKA) were included in this randomized trial to determine the efficacy of periarticular multimodal drug injections (PMDI), as an adjunct to multimodal pain control protocols that have already been shown to provide sufficient analgesic effects for TKA. Patients received either PMDI with the standard pain control protocol or the standard pain control protocol alone. Results over the course of this trial indicated that the addition of PMDI provided significant reductions in post-operative pain and opioid use over the first 24 hours compared to the standard pain control protocol alone, without increasing the incidence of complications.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
